SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-016579
Filing Date
2019-08-13
Accepted
2019-08-13 16:41:41
Documents
44
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20190331b_10q.htm 10-Q 852393
2 EXHIBIT 31.1 ex_147950.htm EX-31.1 15888
3 EXHIBIT 31.2 ex_147951.htm EX-31.2 12559
4 EXHIBIT 32.1 ex_147952.htm EX-32.1 9829
  Complete submission text file 0001437749-19-016579.txt   3222884

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnpx-20190630.xml EX-101.INS 406376
6 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20190630.xsd EX-101.SCH 33658
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20190630_cal.xml EX-101.CAL 23132
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20190630_def.xml EX-101.DEF 250437
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20190630_lab.xml EX-101.LAB 226631
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20190630_pre.xml EX-101.PRE 267836
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 191021250
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1